chitosan has been researched along with tobramycin in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 4 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Buri, P; Felt, O; Furrer, P; Gurny, R; Mayer, JM; Plazonnet, B | 1 |
| Baeyens, V; Buri, P; Felt, O; Gurny, R | 1 |
| Di Colo, G; Zaino, C; Zambito, Y | 1 |
| Bernkop-Schnürch, A; Hombach, J; Hoyer, H | 1 |
| Franzblau, S; Lu, E; Onyuksel, H; Popescu, C | 1 |
| Abdelghany, SM; Deacon, J; Donnelly, RF; Elborn, JS; Gilmore, BF; Jones, DS; Kissenpfennig, A; Megaw, J; Quinn, DJ; Schmid, D; Scott, CJ; Taggart, CC | 1 |
| Reighard, KP; Schoenfisch, MH | 1 |
| Dixon, GA; Hill, DB; Reighard, KP; Schoenfisch, MH; Worley, BV | 1 |
| Ahn, D; Armstrong, DG; Haggard, W; Harris, M; Hatch, D; Jennings, JA; Patel, N; Wells, CM | 1 |
| Cheng, Y; Jia, Z; Li, M; Xiong, P; Yan, J; Zheng, Y; Zhou, W | 1 |
| Jain, N; Kaul, S; Nagaich, U; Pandey, J | 1 |
| Guo, B; Han, Y; Huang, Y; Mu, L; Zhao, X | 1 |
| Abbasi, SA; Ali, S; Andleeb, S; Awan, UA; Imdad, K; Mughal, TA; Nasreen, S; Raja, SA | 1 |
| Duan, C; Feng, X; Guan, D; Hu, Y; Huang, C; Huang, M; Li, X; Liu, Q; Lu, D; Ma, G; Shi, H; Su, S; Wang, J; Wen, Z; Xu, A; Yuan, H; Zhang, N; Zhang, X | 1 |
14 other study(ies) available for chitosan and tobramycin
| Article | Year |
|---|---|
Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention.
Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Chitin; Chitosan; Cornea; Gamma Cameras; Gels; Hydrogen-Ion Concentration; Male; Microscopy, Confocal; Ophthalmic Solutions; Rabbits; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Pentetate; Tobramycin; Viscosity | 1999 |
Delivery of antibiotics to the eye using a positively charged polysaccharide as vehicle.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Biological Availability; Biopolymers; Chitin; Chitosan; Dosage Forms; Drug Delivery Systems; Eye; Male; Molecular Structure; Molecular Weight; Ofloxacin; Rabbits; Solubility; Solutions; Tears; Time Factors; Tobramycin; Treatment Outcome | 2001 |
Effects of N-trimethylchitosan on transcellular and paracellular transcorneal drug transport.
Topics: Absorption; Animals; Biocompatible Materials; Chemistry, Pharmaceutical; Chitosan; Cornea; Drug Delivery Systems; Male; Microspheres; Mucous Membrane; Polymers; Rabbits; Technology, Pharmaceutical; Time Factors; Tobramycin | 2006 |
Thiolated chitosans: development and in vitro evaluation of an oral tobramycin sulphate delivery system.
Topics: Acetylcysteine; Administration, Oral; Animals; Biological Transport; Caco-2 Cells; Chitosan; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Epithelial Cells; Glutathione; Humans; In Vitro Techniques; Intestinal Mucosa; Intestine, Small; Male; Molecular Structure; Rats; Rats, Sprague-Dawley; Sulfhydryl Compounds; Tablets; Technology, Pharmaceutical; Tobramycin; Verapamil | 2008 |
Preparation of aminoglycoside-loaded chitosan nanoparticles using dextran sulphate as a counterion.
Topics: Administration, Oral; Aminoglycosides; Animals; Anti-Bacterial Agents; Chitosan; Dextran Sulfate; Gentamicins; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Nanoparticles; Streptomycin; Tobramycin; Tuberculosis | 2009 |
Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase).
Topics: Adult; Alginates; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Chitosan; Cystic Fibrosis; Deoxyribonuclease I; DNA; Glucuronic Acid; Hexuronic Acids; Humans; Microbial Sensitivity Tests; Nanoparticles; Pseudomonas aeruginosa; Pseudomonas Infections; Recombinant Proteins; Sputum; Tobramycin; Treatment Outcome | 2015 |
Antibacterial Action of Nitric Oxide-Releasing Chitosan Oligosaccharides against Pseudomonas aeruginosa under Aerobic and Anaerobic Conditions.
Topics: Aerobiosis; Anaerobiosis; Anti-Bacterial Agents; Azo Compounds; Biofilms; Chitosan; Glycosaminoglycans; Microbial Sensitivity Tests; Nitric Oxide; Nitric Oxide Donors; Oxygen; Pseudomonas aeruginosa; Tobramycin | 2015 |
Disruption and eradication of P. aeruginosa biofilms using nitric oxide-releasing chitosan oligosaccharides.
Topics: Anti-Bacterial Agents; Biofilms; Chitosan; Nitric Oxide; Oligosaccharides; Pseudomonas aeruginosa; Rheology; Tobramycin | 2015 |
Characteristics and clinical assessment of antibiotic delivery by chitosan sponge in the high-risk diabetic foot: a case series.
Topics: Adult; Anti-Bacterial Agents; Bandages; Chitosan; Diabetic Foot; Doxycycline; Foot Injuries; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Staphylococcus aureus; Surgical Sponges; Tobramycin; Wound Infection | 2017 |
Novel pH-responsive tobramycin-embedded micelles in nanostructured multilayer-coatings of chitosan/heparin with efficient and sustained antibacterial properties.
Topics: Animals; Anti-Bacterial Agents; Cell Line, Tumor; Chitosan; Coated Materials, Biocompatible; Gentamicins; Heparin; Hydrogen-Ion Concentration; Mice; Micelles; Nanostructures; Staphylococcus aureus; Tobramycin | 2018 |
Investigating The Retention Potential of Chitosan Nanoparticulate Gel: Design, Development,
Topics: Animals; Calibration; Chick Embryo; Chitosan; Cornea; Delayed-Action Preparations; Drug Liberation; Drug Stability; Excipients; Gels; Goats; Microbial Sensitivity Tests; Nanoparticles; Particle Size; Tobramycin; Toxicity Tests, Acute | 2020 |
Bacterial Growth-Induced Tobramycin Smart Release Self-Healing Hydrogel for
Topics: Anti-Bacterial Agents; Antioxidants; Burns; Chitosan; Escherichia coli; Humans; Hydrogels; Polymers; Pseudomonas aeruginosa; Pyrroles; Staphylococcal Infections; Tobramycin; Wound Healing; Wound Infection | 2022 |
Screening of Antibacterial Efficacy of Chitosan Encapsulated Probiotics (Lactococcus lactis and Lactobacillus curvattus) against Clinical Bacterial Pathogens.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Buffaloes; Ceftriaxone; Cephalothin; Cephradine; Chitosan; Chloramphenicol; Ciprofloxacin; Erythromycin; Lactobacillus; Lactococcus lactis; Probiotics; Tetracyclines; Tobramycin | 2022 |
A highly stretchable, adhesive, and antibacterial hydrogel with chitosan and tobramycin as dynamic cross-linkers for treating the infected diabetic wound.
Topics: Anti-Bacterial Agents; Chitosan; Diabetes Mellitus; Humans; Hydrogels; Staphylococcal Infections; Tobramycin | 2024 |